Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVNC Revance Therapeutics Inc

盘前交易 10-24 07:41:51 EDT

5.29

+0.00

0.00%

最高5.33	最低5.22	成交量86.48万
今开5.28	昨收5.29	日振幅1.98%
总市值5.55亿	流通市值4.52亿	总股本1.05亿
成交额457.36万	换手率1.01%	流通股本8,538万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVNC","market":"US","secType":"STK","nameCN":"Revance Therapeutics Inc","latestPrice":5.29,"timestamp":1729713600000,"preClose":5.29,"halted":0,"volume":864811,"delay":0,"floatShares":85381611,"shares":104823331,"eps":-3.113876,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"10-24 07:41:51 EDT","open":5.28,"high":5.325,"low":5.22,"amount":4573625.0122563,"amplitude":0.019849,"askPrice":5.39,"askSize":50,"bidPrice":5.16,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.113876,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1729776600000},"adr":0,"listingDate":1391662800000,"adjPreClose":5.29,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5.29,"preClose":5.29,"latestTime":"19:26 EDT","volume":33649,"amount":178000.77,"timestamp":1729725983169},"volumeRatio":0.8197372551970328,"impliedVol":1.0651,"impliedVolPercentile":0.239},"requestUrl":"/m/hq/s/RVNC","defaultTab":"news","newsList":[{"id":"2470419964","title":"Revance Therapeutics, Inc.盘中异动 临近午盘股价大涨5.03%报5.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470419964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470419964?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:58","pubTimestamp":1727193506,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时58分，Revance Therapeutics, Inc.股票出现波动，股价快速拉升5.03%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Capricor Therapeutics, Inc.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4051.28%、183.22%、134.30%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为101.84%、58.52%、45.08%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423582798e38b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423582798e38b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4007","RVNC","BK4588","BK4585","BK4139","LENZ"],"gpt_icon":0},{"id":"2469186112","title":"Revance Therapeutics, Inc.股价重挫10.33% 市值跌5606.93万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469186112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469186112?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:31","pubTimestamp":1727098282,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时31分，Revance Therapeutics, Inc.股票出现波动，股价大幅跳水10.33%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Pharmacyte  Biotech, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Black Diamond Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Scisparc Ltd.较为活跃，换手率分别为25.57%、22.42%、22.18%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、天演药业、Xtl生物制药，振幅分别为18.52%、13.14%、8.81%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232131229f106f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232131229f106f25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","RVNC","LENZ","BK4007","LU0053671581.USD"],"gpt_icon":0},{"id":"2460706735","title":"Revance Therapeutics, Inc.2024财年第二财季实现净利润-37.47百万美元，同比增加44.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460706735","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460706735?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:03","pubTimestamp":1723910629,"startTime":"0","endTime":"0","summary":"8月18日，Revance Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-37.47百万美元，同比增加44.34%；其中营业收入为65.39百万美元，同比增加12.49%，每股基本收益为-0.36美元。从资产负债表来看，Revance Therapeutics, Inc.总负债6.25亿美元，其中短期债务31.61百万美元，资产负债比为0.80，流动比率为0.04。机构评级：截至2024年8月18日，当前有7家机构对Revance Therapeutics, Inc.目标价做出预测，其中目标均价为11.71美元，其中最低目标价为6.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006029f3406e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006029f3406e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVNC","LENZ"],"gpt_icon":0},{"id":"2459937738","title":"BUZZ--美国股票走势-Revance, B Riley, Neuronetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2459937738","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459937738?lang=zh_cn&edition=full","pubTime":"2024-08-13 02:26","pubTimestamp":1723487209,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月12日 - 美国股市周一在寻找方向的过程中陷入困境，投资者正在为本周的一系列经济数据做准备，他们重点关注美国消费者物价，以衡量美联储货币政策路径的前景。美东时间13:44，道琼斯工业平均指数  为!标普500指数  上涨0.01%，报5344.68点；纳斯达克综合指数  上涨0.35%，报16803.296点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DJX","LU2756315318.SGD","SMCI","IE0009355771.USD","LU0820561909.HKD","LU0689472784.USD","COHR","LU1861558580.USD","DDM","TQQQ",".SPX","NVDA","QID","PSQ","WVE","NQmain","HD","TJX","KEY","DLTR","DG","LU0096364046.USD","ULCC",".DJI","STIM","QLD","SQQQ","UDOW","LU2505996509.AUD","LU2505996681.GBP","HE","IBM","LU0175139822.USD","JBLU","LU0097036916.USD","HPE","BUZZ","DXD","RILY","DOG","HUMA","RVNC","SDOW","MNQmain",".IXIC"],"gpt_icon":1},{"id":"2459377339","title":"BUZZ--美国股票走势-Revance, B Riley, Neuronetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2459377339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459377339?lang=zh_cn&edition=full","pubTime":"2024-08-13 02:26","pubTimestamp":1723487209,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月12日 - 美国股市周一在寻找方向的过程中陷入困境，投资者正在为本周的一系列经济数据做准备，他们重点关注美国消费者物价，以衡量美联储货币政策路径的前景。美东时间13:44，道琼斯工业平均指数  为!标普500指数  上涨0.01%，报5344.68点；纳斯达克综合指数  上涨0.35%，报16803.296点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD",".SPX","BUZZ","SQQQ","TQQQ","LU0175139822.USD","HPE","LU0820561909.HKD","LU2505996681.GBP","LUMN","JBLU","TJX","UDOW","SBUX","DLTR",".IXIC","LU0096364046.USD","RILY","HE","KEY","DJX","NQmain","LU2756315318.SGD","STIM","ULCC","DXD","CLSK","LU1861558580.USD","LU0097036916.USD","QLD","HUMA","HD","LLY",".DJI","DG","PSQ","HOOD","LU2505996509.AUD","QID","WVE","SDOW","COHR","IBM","MNQmain","RVNC","LU0689472784.USD","DOG","DDM"],"gpt_icon":1},{"id":"2458498510","title":"今日优惠-合并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2458498510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458498510?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:38","pubTimestamp":1723469928,"startTime":"0","endTime":"0","summary":"     路透8月12日 - 截至格林尼治标准时间周一 1330 时，有以下竞购、兼并、收购和处置报告：    ** 抗皱注射剂生产商Revance Therapeutics   已同意被私人控股的Crown Laboratories收购，交易价值9.24亿美元，包括债务在内。** 英国竞争监督机构表示，它正在调查芯片设计软件制造商Synopsys  斥资350亿美元收购Ansys  是否会影响英国的竞争。** 英国皇家邮政母公司国际配送服务公司  宣布，其包裹服务业务GLS将把美国货运部门出售给总部位于加利福尼亚州的DC物流公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","RVNC","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2458985111","title":"Revance Therapeutics, Inc.盘中异动 股价大涨85.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458985111","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458985111?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469484,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Revance Therapeutics, Inc.股票出现波动，股价快速拉升85.55%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。消息层面，截至21时31分，Revance Therapeutics, Inc.股票正面舆情新闻比例33.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131249f248f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131249f248f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVNC","LENZ","BK4588","LU0053671581.USD","BK4585","BK4139","BK4007"],"gpt_icon":0},{"id":"2458298322","title":"BUZZ--美国股票走势-Revance Therapeutics、B Riley Financial、KeyCorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2458298322","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458298322?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:27","pubTimestamp":1723469245,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月12日 - 华尔街周一将高开高走，股指将从上周初的重挫中回升，投资者将为包括美国消费者价格在内的大量数据做好准备。美东时间9:06，道指电子盘  上涨0.12%，报39,688 点。标普500指数小型股  上涨0.21%，报5,381.5点；纳斯达克100指数小型股  上涨0.25%，报18,661.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1814569148.SGD","BK4211","BK4504","BK4588","LU0289960550.SGD","LU1585245621.USD","BK4500","LU2506952097.USD","RVNC","LU0823417653.USD","LENZ","KEY","LU2125154935.USD","BK4155","GNLN","BUZZ","LU2506952170.USD","LU0094547139.USD","BK4159","LU2506951958.HKD","IE00B19Z9Z06.USD","IE0031619046.USD","BK4534","BK4532","BK4581","HUMA","RILY","LU2360032135.SGD","LU2092937221.SGD","DLTR","LU1035773651.USD","BK4139","LU1988902786.USD","TJX","IE00B894F039.SGD","BK4592","LU1064131342.USD","LU2125154778.USD","LU2133065610.SGD","LU1430594728.SGD","BK4589","BK4081","JBLU","LU0053671581.USD","BK4127","LU0417517546.SGD","LU0640476718.USD","HE"],"gpt_icon":1},{"id":"2458764607","title":"BUZZ-Revance 因被 Crown Laboratories 以 9.24 亿美元收购而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2458764607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458764607?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:39","pubTimestamp":1723466349,"startTime":"0","endTime":"0","summary":"    8月12日 - ** 抗皱注射剂生产商Revance Therapeutics   股价盘前上涨84.7%，至6.52美元** RVNC称，  私人护肤品公司Crown Laboratories将收购RVNC，包括债务在内的私有化交易价值为9.24亿美元。** Crown将以每股6.66美元的现金收购RVNC股票，较该股最后收盘价溢价约89%。** 交易预计在年底前完成** Revance 公司生产的 Daxxify 是艾伯维公司    广受欢迎的抗皱注射剂肉毒杆菌毒素的竞争对手。** 截至上一交易日收盘，RVNC股价年累计下跌约60","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","RVNC","BK4007","BUZZ","LU0053671581.USD"],"gpt_icon":0},{"id":"2458604477","title":"抗皱注射剂生产商 Revance 将通过 9.24 亿美元的交易实现私有化","url":"https://stock-news.laohu8.com/highlight/detail?id=2458604477","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458604477?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:07","pubTimestamp":1723464468,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月12日 - 抗皱注射剂生产商Revance Therapeutics   和私人护肤品公司Crown Laboratories周一表示，两家公司将以私有化的方式收购Revance Therapeutics   ，包括债务在内的交易价值为9.24亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","RVNC","BK4007","BK4588","BK4585"],"gpt_icon":0},{"id":"2458515563","title":"BUZZ-Revance Therapeutics 美容产品第二季度销售额增加，业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2458515563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458515563?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:14","pubTimestamp":1723220040,"startTime":"0","endTime":"0","summary":"    8月9日 - ** 美容药品制造商 Revance Therapeutics    股价上涨约 21%，报 3.55 美元** 该公司是纳斯达克生物技术指数  中涨幅最大的公司之一 ** 周四晚些时候，Revance公布第二季度产品净收入为6540万美元，去年同期为5440万美元。** RVNC 的产品收入包括抗皱注射剂 Daxxify 和面部填充剂 RHA Collection 的销售收入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","RVNC","BK4007","BK4588","BK4585","BK0235","002798"],"gpt_icon":0},{"id":"2458595423","title":"Revance Therapeutics, Inc.盘中异动 急速上涨11.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458595423","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458595423?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210295,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时31分，Revance Therapeutics, Inc.股票出现波动，股价快速拉升11.86%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Adma Biologics Inc涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为32.77%、5.41%、4.90%，振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Enliven Therapeutics, Inc.、Relmada Therapeutics, Inc.，振幅分别为10.21%、9.58%、9.57%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131369f1dc151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131369f1dc151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","LENZ","RVNC","BK4007","BK4585","BK4588"],"gpt_icon":0},{"id":"2457873406","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.19%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457873406","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457873406?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:35","pubTimestamp":1723055713,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日02时35分，Revance Therapeutics, Inc.股票出现波动，股价快速下跌5.19%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.59%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5153.88%、2606.04%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、62.37%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808023513aefdbecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808023513aefdbecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0053671581.USD","BK4139","LENZ","BK4585","BK4007","RVNC"],"gpt_icon":0},{"id":"2457776656","title":"Revance Therapeutics, Inc.股价重挫12.66% 市值跌3695.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457776656","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457776656?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:42","pubTimestamp":1722865341,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时42分，Revance Therapeutics, Inc.股票出现波动，股价大幅下跌12.66%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Cervomed Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1101.40%、54.51%、14.22%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Alpha Tau Medical Ltd C/Wts 、Cns Pharmaceuticals, Inc.，振幅分别为27.34%、26.68%、21.59%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214221957f34d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214221957f34d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RVNC","BK4588","LENZ","BK4007","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2456728112","title":"Revance Therapeutics, Inc.盘中异动 大幅跳水5.34%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456728112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456728112?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:36","pubTimestamp":1722605769,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时36分，Revance Therapeutics, Inc.股票出现波动，股价急速下挫5.34%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为396.36%、229.63%、22.31%，振幅较大的相关个股有Exicure, Inc.、Dermata Therapeutics, Inc.、Os Therapies Incorporated，振幅分别为33.34%、31.45%、22.31%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022136109682341f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022136109682341f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","RVNC","BK4588","BK4139","LENZ","LU0053671581.USD"],"gpt_icon":0},{"id":"2456433096","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.03%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456433096","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456433096?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:54","pubTimestamp":1722520460,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时54分，Revance Therapeutics, Inc.股票出现波动，股价大幅下跌5.03%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Immuneering Corporation、Biomea Fusion, Inc.、Genenta Science Spa涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为150.25%、58.25%、18.23%，振幅较大的相关个股有Immuneering Corporation、Neurosense Therapeutics Ltd.、Biomea Fusion, Inc.，振幅分别为29.20%、27.17%、24.33%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012154209719879a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012154209719879a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","RVNC","BK4585","BK4007","LENZ","LU0053671581.USD"],"gpt_icon":0},{"id":"2456154102","title":"Revance Therapeutics, Inc.盘中异动 大幅拉升5.14%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456154102","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456154102?lang=zh_cn&edition=full","pubTime":"2024-08-01 00:10","pubTimestamp":1722442257,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日00时10分，Revance Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Renovaro Inc.、Applied Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为154.31%、147.53%、140.90%，振幅较大的相关个股有Renovaro Inc.、Alpha Tau Medical Ltd C/Wts 、Salarius Pharmaceuticals, Inc.，振幅分别为79.10%、44.12%、40.61%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801001057aefc7de3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801001057aefc7de3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","RVNC","LENZ","BK4007","LU0053671581.USD"],"gpt_icon":0},{"id":"2454040148","title":"Revance Therapeutics, Inc.盘中异动 大幅拉升5.09%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454040148","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454040148?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:57","pubTimestamp":1721926639,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时57分，Revance Therapeutics, Inc.股票出现异动，股价大幅上涨5.09%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为4663.52%、556.67%、279.61%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为152.48%、132.26%、98.60%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726005719aefb7b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726005719aefb7b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LENZ","BK4007","RVNC","LU0053671581.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2454821038","title":"免疫学药物销售强劲，艾伯维上调年度盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2454821038","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454821038?lang=zh_cn&edition=full","pubTime":"2024-07-25 19:36","pubTimestamp":1721907396,"startTime":"0","endTime":"0","summary":"    路透7月25日 - 艾伯维  周四上调了年度利润预期，因为包括Humira在内的主要免疫学药物的强劲销售帮助其第二季度业绩超过了华尔街的预期。艾伯维在2月 ，预计今年Humira在美国的销售额将下降36%。该制药公司及其投资者一直关注较新的免疫学药物Skyrizi和Rinvoq的销售，以抵消Humira需求的减少。第二季度，该抗癌药的全球销售额下降了 8%，降至 8.33 亿美元，但仍超过了 7.89 亿美元的预期。调整后，艾伯维每股收益为 2.65 美元，超出预期 8 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","IE00BSNM7G36.USD","LU1037948541.HKD","LU1244550577.SGD","LU0289739699.SGD","LU0265550946.USD","IE00B7SZLL34.SGD","LU0965508806.USD","LU1934455194.USD","LU1934455277.USD","IE00BFSS8Q28.SGD","IE00BWXC8680.SGD","LU0058720904.USD","LU0211326839.USD","RVNC","LU0545039389.USD","LU0868494617.USD","LU0187121727.USD","LU1261432733.SGD","LU1699723380.USD","LU0094547139.USD","LU0417517546.SGD","ABBV","IE00B1XK9C88.USD","MRK","IE00B19Z3581.USD","CI","IE00B19Z9P08.USD","EOLS","LU1496350502.SGD","IE00BFSS7M15.SGD","IE00BBT3K403.USD","LU0266013472.USD","IE00B894F039.SGD","IE00B1BXHZ80.USD","LU0158827948.USD","IE00BLSP4239.USD","IE0002270589.USD","LU1037948897.HKD","LU1066051498.USD","LU0109391861.USD","LU1941712348.USD","IE00B19Z3B42.SGD","CVS","LU0256863902.USD","IE0005OL40V9.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2453884134","title":"Revance Therapeutics, Inc.盘中异动 急速跳水5.27%报4.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453884134","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453884134?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:13","pubTimestamp":1721834018,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时13分，Revance Therapeutics, Inc.股票出现波动，股价急速下挫5.27%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7712.48%、1205.66%、626.90%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.79%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724231338aefb4250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724231338aefb4250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4585","BK4588","RVNC","BK4007","LU0053671581.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revance.com","stockEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":-0.014},{"period":"3month","weight":0.4069},{"period":"6month","weight":0.5559},{"period":"1year","weight":-0.3884},{"period":"ytd","weight":-0.3982}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":0.0146},{"period":"3month","weight":0.0735},{"period":"6month","weight":0.1372},{"period":"1year","weight":0.3644},{"period":"ytd","weight":0.216}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revance Therapeutics, Inc.于1999年8月10日成立于特拉华公司，当时名为Essentia Biosystems公司。公司是一家处于专业临床阶段的生物制药公司，专注于开发、制造和商业化用以美容和治疗的异常型肉毒杆菌毒素产品。肉毒杆菌毒素是一种良好的蛋白，目前广泛应用于美容和治疗适应症，在美国和其他国家是一个数十亿美元的市场。目前批准和商用的肉毒杆菌毒素都是注入型的。RT001, 公司的主要候选产品，是a型肉毒毒素局部配方,相对于现有注射肉毒杆菌毒素市场产品，被认为有显著的优势。公司的第二个候选产品RT002，是一种新型注射肉毒杆菌毒素类型的配方，其设计更有针对性，与其他肉毒杆菌毒素注射产品相比，更持久。这些候选产品，结合了公司的净化肉毒杆菌毒素和专有肽输送系统。公司对其两个候选产品，在全球拥有发行权利。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.017146},{"month":2,"riseRate":0.6,"avgChangeRate":0.034292},{"month":3,"riseRate":0.363636,"avgChangeRate":0.011213},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.023839},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.009304},{"month":6,"riseRate":0.636364,"avgChangeRate":0.025437},{"month":7,"riseRate":0.272727,"avgChangeRate":0.019423},{"month":8,"riseRate":0.454545,"avgChangeRate":0.053158},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.007424},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.066952},{"month":11,"riseRate":0.3,"avgChangeRate":-0.003095},{"month":12,"riseRate":0.6,"avgChangeRate":0.084189}],"exchange":"NASDAQ","name":"Revance Therapeutics Inc","nameEN":"Revance Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revance Therapeutics Inc,RVNC,Revance Therapeutics Inc股票,Revance Therapeutics Inc股票老虎,Revance Therapeutics Inc股票老虎国际,Revance Therapeutics Inc行情,Revance Therapeutics Inc股票行情,Revance Therapeutics Inc股价,Revance Therapeutics Inc股市,Revance Therapeutics Inc股票价格,Revance Therapeutics Inc股票交易,Revance Therapeutics Inc股票购买,Revance Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况